Recombinant EGFR (Cetuximab Biosimilar) antibody

Catalog No. ABIN7884628

The Human Monoclonal anti-EGFR (Cetuximab Biosimilar) antibody is suitable to detect EGFR (Cetuximab Biosimilar) in samples from Human. It has been validated for FACS, ELISA, IHC and IFA.

Quick Overview for Recombinant EGFR (Cetuximab Biosimilar) antibody (ABIN7884628)

Target: EGFR (Cetuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This EGFR (Cetuximab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), ELISA, Immunohistochemistry (IHC), Indirect Immunofluorescence Assay (IFA)

Clone: C225

Product Details anti-EGFR (Cetuximab Biosimilar) Antibody

Purpose: Human anti-EGFR Antibody, Clone C225 (Cetuximab Biosimilar)

Characteristics: Cetuximab biosimilar is a recombinant monoclonal antibody which binds specifically to the human epidermal growth factor receptor (EGFR). Cetuximab biosimilar interacts with the extracellular region of EGFR to block ligand stimulation and has potent antitumor efficacy. This product is for research use only.

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: Azide free-phosphate buffered saline

Preservative: Without preservative

Storage: -20 °C

Storage Comment: Store at -20°C.

Target Details for EGFR (Cetuximab Biosimilar)

Target: EGFR (Cetuximab Biosimilar)

Molecular Weight:  134 kDa

Gene ID: 1956

NCBI Accession: NG_007726

UniProt: P00533